Literature DB >> 3220086

Cellular distribution patterns of estrogen receptor in human breast cancer.

J P van Netten1, J B Armstrong, S J Carlyle, N L Goodchild, I G Thornton, M L Brigden, P Coy, C Fletcher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3220086     DOI： 10.1016/0277-5379(88)90105-8

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  4 in total

Review 1.  Endocrine therapy for advanced breast cancer: a review.

Authors:  H B Muss
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer.

Authors:  Mary L Gemignani; Sujata Patil; Venkatraman E Seshan; Michelle Sampson; John L Humm; Jason S Lewis; Edi Brogi; Steven M Larson; Monica Morrow; Neeta Pandit-Taskar
Journal:  J Nucl Med       Date:  2013-08-22       Impact factor: 10.057

3.  The Predictive Value of Early Changes in 18 F-Fluoroestradiol Positron Emission Tomography/Computed Tomography During Fulvestrant 500 mg Therapy in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer.

Authors:  Min He; Cheng Liu; Qin Shi; Yuyun Sun; Yongping Zhang; Xiaoping Xu; Huiyu Yuan; Yingjian Zhang; Yin Liu; Guangyu Liu; Genhong Di; Zhongyi Yang; Zhonghua Wang; Zhiming Shao
Journal:  Oncologist       Date:  2020-04-28

4.  A preliminary study of 18F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel.

Authors:  Chengcheng Gong; Zhongyi Yang; Yifei Sun; Jian Zhang; Chunlei Zheng; Leiping Wang; Yongping Zhang; Jing Xue; Zhifeng Yao; Herong Pan; Biyun Wang; Yingjian Zhang
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.